In this video, Allen C. Gao, MD, PhD, discusses the background and findings of the study, “Resistance to olaparib is dependent on re-emergence from G2/M arrested senescence,” presented at the 2021 American Urological Association Annual Meeting. Gao is the Ralph de Vere White professor in the department of urologic surgery and director of urologic research at University of California, Davis.
KIM-1 emerges as biomarker for MRD, atezolizumab benefit in renal cell carcinoma
June 3rd 2024Circulating kidney injury molecule-1 (KIM-1) may be a biomarker for minimal residual disease, disease recurrence, and benefit from adjuvant atezolizumab in patients with renal cell carcinoma at increased risk of recurrence, according to a retrospective analysis of the phase 3 IMmotion010 trial.